section name header

Information

Diagnostic Approach of Infants Born to Mothers With Reactive Serologic Tests for Syphilis !!flowchart!!

mainimage

Evaluation and Treatment of Infants Up to 1 Month of Age With Possible, Probable, or Confirmed Congenital Syphilisa

Category

Findings

Recommended Evaluation

Treatment

Proven or highly
probable congenital
syphilis

  • Abnormal physical examination consistent with congenital syphilis

OR

  • A serum quantitative nontreponemal serologic titer fourfold (or greater) higher than the birthing parent’s titer at delivery (eg, maternal titer = 1:2, neonatal titer >=1:8; or maternal titer = 1:8, neonatal titer >=1:32)

OR

  • A positive result of darkfield test or PCR assay of lesions or body fluid(s)
  • CSF analysis (CSF VDRL, cell count, and protein)
  • CBC with differential and platelet count
  • Other tests (as clinically indicated):
    • Chest radiography
    • Aminotransferases
    • Neuroimaging
    • Ophthalmologic examination
    • Auditory brain stem response
    • HIV testing
  • Aqueous crystalline penicillin G, 50 000 U/kg, IV, every 12 hours (1 wk or younger), then every 8 h for infants older than 1 wk, for a total of 10 days of therapyb (preferred)

OR

  • Penicillin G procaine, 50 000 U/kg, IM, as single
    daily dose for 10 days

Possible
congenital
syphilis

  • Normal infant examination

AND

  • A serum quantitative nontreponemal serologic titer less than fourfold the birthing parent’s titer at delivery (eg, maternal titer = 1:8, neonatal titer 1:16)

AND ONE OF THE FOLLOWING

  • Birthing parent was not treated, was inadequately treated, or had no documentation of receiving treatment;

OR

  • Birthing parent was treated with a regimen other than recommended in the guideline (ie, a nonpenicillin G regimen)

OR

  • Birthing parent received recommended regimen but treatment was initiated <30 days before delivery
  • CSF analysis (CSF VDRL, cell count, and protein)
  • CBC with differential and platelet count
  • Long-bone radiography
  • Aqueous crystalline penicillin G, 50 000 U/kg, IV, every 12 h (1 wk or younger), then every 8 h for infants older than 1 wk, for a total of 10 days of therapya (preferred)

OR

  • Penicillin G procaine, 50 000 U/kg, IM, as single
    daily dose for 10 days

OR

  • Penicillin G benzathine, 50 000 U/kg, IM, single dose (recommended by some experts, but only if all components of the evaluation are obtained and are normalc and follow-up is certain)

Congenital syphilis
less likely

  • Normal infant examination

AND

  • A serum quantitative nontreponemal serologic titer less than fourfold the birthing parent’s titer at delivery (eg, maternal titer = 1:8, neonatal titer 1:16)

AND

  • Birthing parent was treated during pregnancy, treatment was appropriate for stage of infection, and treatment was administered >=30 days before delivery

AND

  • Birthing parent has no evidence of reinfection or relapse
  • Not recommended
  • Penicillin G benzathine, 50 000 U/kg, IM, single dose (preferred)
  • Alternatively, infants whose birthing parent’s non­treponemal titers decreased at least fourfold after appropriate therapy for early syphilis or remained stable at low titer (eg, VDRL 1:2; RPR 1:4) may be followed every 2–3 mo without treatment until the nontreponemal test becomes nonreactive
  • Nontreponemal antibody titers should decrease by 3 mo of age and should be nonreactive by 6 mo of age; patients with increasing titers or with persistent stable titers 6–12 mo after initial treatment should be reevaluated, including a CSF examination, and treated with a 10-day course of parenteral penicillin G, even if they were treated previously

Congenital syphilis is unlikely

  • Normal infant examination

AND

  • A serum quantitative nontreponemal serologic titer less than fourfold the birthing parent’s titer at delivery

AND

  • Birthing parent was treated adequately before pregnancy

AND

  • Birthing parent nontreponemal serologic titer remained low and stable (ie, serofast) before and during pregnancy and at delivery (eg, VDRL 1:2; RPR 1:4)
  • Not recommended
  • None, but infants with reactive nontreponemal
    tests should be followed serologically to ensure test result returns to negative
  • Penicillin G benzathine, 50 000 U/kg, IM, single dose can be considered if follow-up is uncertain and infant has a reactive test (some experts)
  • Neonates with a negative nontreponemal test result at birth and whose birthing parent was seroreactive at delivery should be retested at
    3 mo to rule out incubating congenital syphilis

CBC indicates complete blood cell count; CSF, cerebrospinal fluid; IM, intramuscularly; IV, intravenously; PCR, polymerase chain reaction; RPR, rapid plasma reagin; VDRL, Venereal Disease Research Laboratory.

a For treatment of infants >=1 month of age with congenital syphilis, see the chapter on Syphilis in the 2024 Red Book.

b If 24 hours or more of therapy is missed, the entire course must be restarted.

c If CSF is not obtained or uninterpretable (eg, bloody tap), a 10-day course is recommended.

Adapted and modified from Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(RR-4):52-54.